SMMT: Summit Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,631.39
Enterprise Value ($M) 2,759.96
Book Value ($M) 77.69
Book Value / Share 0.11
Price / Book 33.87
NCAV ($M) 64.45
NCAV / Share 0.09
Price / NCAV 40.83

Profitability (mra)
Return on Invested Capital (ROIC) -2.17
Return on Assets (ROA) -0.93
Return on Equity (ROE) -4.86

Liquidity (mrq)
Quick Ratio 9.30
Current Ratio 9.30

Balance Sheet (mrq) ($M)
Current Assets 189.71
Assets 202.95
Liabilities 125.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -88.73
Net Income -614.93

Cash Flow Statement (mra) ($M)
Cash From Operations -76.76
Cash from Investing -587.77
Cash from Financing 86.51

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2023-03-13 13D/A Zanganeh Maky 5.27

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 952,885 4,250,280 22.42
2024-03-27 263,014 1,175,004 22.38
2024-03-26 615,583 2,987,043 20.61
2024-03-25 373,580 1,843,144 20.27

(click for more detail)

Similar Companies
SGMT – Sagimet Biosciences Inc. SIGA – SIGA Technologies, Inc.
SLGL – Sol-Gel Technologies Ltd. SNSE – Sensei Biotherapeutics, Inc.
SPRY – ARS Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io